Bioengineering review
As individuals infected with HIV experience increased longevity, the landscape of health challenges associated with HIV has shifted dramatically. Notably, non-AIDS-related mortality has surged, with liver disease emerging as a leading cause of death in this population. The epidemiology of liver diseases is complex, encompassing a diverse range of conditions, including viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), and liver cancer. This evolutionary shift necessitates a detailed examination of the multifactorial landscape of liver disease among people living with HIV.
Recent findings highlight a concerning rise in various liver diseases, driven by factors that go beyond traditional viral infections. The complexities of HIV infection can exacerbate liver conditions, making it critical to address the interplay of these diseases. Many individuals with HIV co-infected with hepatitis B or C virus are at a heightened risk for liver-related complications. The study, published in Nature Reviews Gastroenterology & Hepatology, underscores the urgent need for systematic screening and management strategies to mitigate liver disease burden in this population.
Read the full review here.
Source : Bioengineering
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.